Engineered gut bacteria match fecal transplants in small C. difficile trial
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access to microbiome-based ...
Jun 2, 2026
0
9









